Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group. Kuller LH, et al. Among authors: de wit s, nixon d. PLoS Med. 2008 Oct 21;5(10):e203. doi: 10.1371/journal.pmed.0050203. PLoS Med. 2008. PMID: 18942885 Free PMC article.
Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD; INSIGHT SMART Study Group. Baker JV, et al. Among authors: de wit s, nixon de. J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):36-43. doi: 10.1097/QAI.0b013e3181f7f61a. J Acquir Immune Defic Syndr. 2011. PMID: 20930640 Free PMC article. Clinical Trial.
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
Levi LI, Sharma S, Schleiss MR, Furrer H, Nixon DE, Blackstad M, Hernandez-Alvarado N, Dwyer DE, Borges AH, Lane HC, Lundgren J, Neaton JD, Molina JM; INSIGHT ANRS study groups. Levi LI, et al. Among authors: nixon de. AIDS. 2022 Jul 15;36(9):1265-1272. doi: 10.1097/QAD.0000000000003238. Epub 2022 Apr 19. AIDS. 2022. PMID: 35442221 Free PMC article.
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
Baker JV, Neuhaus J, Duprez D, Freiberg M, Bernardino JI, Badley AD, Nixon DE, Lundgren JD, Tracy RP, Neaton JD; INSIGHT SMART Study Group. Baker JV, et al. Among authors: nixon de. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):128-34. doi: 10.1097/QAI.0b013e318252f99f. J Acquir Immune Defic Syndr. 2012. PMID: 22421746 Free PMC article.
Biomarkers of immune dysfunction in HIV.
Nixon DE, Landay AL. Nixon DE, et al. Curr Opin HIV AIDS. 2010 Nov;5(6):498-503. doi: 10.1097/COH.0b013e32833ed6f4. Curr Opin HIV AIDS. 2010. PMID: 20978393 Free PMC article. Review.
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.
Adler SP, Manganello AM, Lee R, McVoy MA, Nixon DE, Plotkin S, Mocarski E, Cox JH, Fast PE, Nesterenko PA, Murray SE, Hill AB, Kemble G. Adler SP, et al. Among authors: nixon de. J Infect Dis. 2016 Nov 1;214(9):1341-1348. doi: 10.1093/infdis/jiw365. Epub 2016 Aug 11. J Infect Dis. 2016. PMID: 27521362 Free PMC article. Clinical Trial.
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
Strategies for Management of Antiretroviral Therapy (SMART) Study Group; Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, et al. J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713. J Infect Dis. 2008. PMID: 18476292 Clinical Trial.
68 results